Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Inari Medical, Inc.

Inari Medical develops and provides products for the treatment of venous thromboembolism (VTE). The company focuses on mechanical thrombectomy systems designed for various venous conditions.

Inari Medical

Inari Medical | 43,692 followers on LinkedIn. Improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. | Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.

Healthcare Leading Growth Executive I Transformation & Results through Goal Achieving Teams and Frontline Leadership

Luis Fonseca

Executive Sales Professional

Paul Sahagian

Tony Bousquette

Account Manager/ Clot Warrior at Inari Medical

Trisha Lopez

Today at #TCT , Dr. Wissam A Jaber (Co-PI) presented results from the #PEERLESS RCT. As the first major pulmonary embolism RCT in a decade—and the first ever to evaluate thrombectomy—PEERLESS marks a pivotal advancement in PE care, setting a new standard for the field. More: https://bit.ly/PEERLESS Carin Gonsalves Cardiovascular Research Foundation

In honor of Veterans Day, we’re proud to share advice from two of our team members—Sean Jennings, former US Air Force Electrical Power Production Journeyman and Base Honor Guard, and Jorge Alaniz, US Army 91B Wheeled Vehicle Mechanic. Their message to veterans transitioning to life after service: be patient with yourself. Take the time you need to discover your passions, pursue them one step at a time, and never hesitate to reach out to your local VA for support. Carrying the strength and values they learned in the military, Sean and Jorge reflect on how their service shaped the skills that continue to guide their success today. To all veterans, we offer our deepest thanks for your service, sacrifice, and the invaluable leadership and strength you bring to everything you do.

At Inari Medical, we're proud to play a key role in helping patients like Adam recover quickly and regain their quality of life. Thanks to Dr. Sebastiano Virgadamo at Spartanburg Regional Healthcare System and the power of the #FlowTriever system, Adam fully recovered. His story is a powerful reminder that innovative technology combined with skilled care, can lead to positive outcomes. Adam's story: https://bit.ly/3YEx7wA More on #FlowTriever : https://bit.ly/4dHrsfk #InariMedical #PatientsFirst

Join us and The PERT Consortium next week for The Clinical PE Story: PEERLESS RCT Comparing FlowTriever to CDT, an in-depth discussion on the #PEERLESS randomized controlled trial results. This session will explore the RCT outcomes and offer valuable clinical insights into the future of PE intervention and patient care. Register here: https://bit.ly/3Uowje9

At 42 years old, Tyler was sidelined by a massive blood clot in his leg. After struggling with pain and swelling for several days, he sought medical attention, where a scan revealed the severity of the clot. Thanks to Dr. Christopher Yi at Orange Coast Memorial and the power of the #ClotTriever system, Tyler's story is one of rapid recovery and renewed hope. Tyler's story went viral after he shared an image of his removed clot on Reddit, raising awareness about #DVT and the importance of timely treatment. We're proud to be a part of this journey, helping patients like Tyler get back to living their fullest lives. Read more about Tyler's story: https://bit.ly/4hBSBTE #InariMedical #PatientsFirst #MedicalInnovation #DVT #ClotAwareness

Learn more about the #PEERLESS RCT, the first major RCT in #pulmonaryembolism in a decade. PEERLESS compared FlowTriever Thrombectomy to Catheter-Directed Thrombolytics (CDT) in 550 intermediate-risk PE patients. #FlowTriever patients experienced: - 0 deaths at discharge or 7 days - Fewer and less severe clinical deteriorations - Less hospital resource use and lower 30-day readmissions Read the publication: https://bit.ly/3YoXFlt More on FT: https://bit.ly/4dHrsfk #InariMedical #MedicalInnovation

Attending #BSIR2024 ? Connect with the #Inari team to explore how #mechanicalthrombectomy is advancing #PE and #DVT management. Don’t miss our symposium, where experts will share insights on building #VTE programs using lytic-free thrombectomy with #FlowTriever and #ClotTriever systems. See you in Brighton! #InterventionalRadiology #HealthcareInnovation

Yesterday evening marked the beginning of a series of meetings among Inari Medical Strategic Advisory Boards, designed to gather invaluable perspectives across specialties. We look forward to collaborating with additional boards to gain insights that will be instrumental as we continue our mission to treat and transform the lives of patients suffering from venous and other diseases. More to come!

Reminder: 2 days until our next #ClotWarriorAcademy webinar! We’ll discuss how #FlowTriever thrombectomy compares to CDT in treating intermediate-risk PE patients, delve into practical implications for PE intervention strategies, and review case examples highlighting intervention selection and outcomes. Register here: https://bit.ly/4hssYED

ICYMI: Dr. Krunal Patel dives into groundbreaking insights from the #FLASH Registry on the impact of expedited mechanical thrombectomy in acute #PE . Learn more: https://bit.ly/4eiOEAc #PulmonaryEmbolism #MechanicalThrombectomy #CHEST2024 #InariMedical #FLASHRegistry #Cardiology #VascularCare #AcuteCare #MedicalInnovation

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	6.83M -	51.13M 648.70%	139.67M 173.17%	276.98M 98.31%	383.47M 38.45%	493.63M 28.73%
cost of revenue	1.28M -	5.91M 361.39%	13.11M 121.74%	24.76M 88.90%	44.51M 79.77%	64.87M 45.75%
gross profit	5.55M -	45.22M 715.04%	126.56M 179.89%	252.23M 99.29%	338.96M 34.39%	428.76M 26.49%
selling and marketing expenses	86 -
general and administrative expenses	10.70M -	37.20M 247.70%
selling general and administrative expenses	10.70M -	37.20M 247.70%	89.75M 141.27%	190.37M 112.12%	292.84M 53.83%	344.86M 17.76%
research and development expenses	3.99M -	7.22M 80.95%	18.40M 154.84%	51.02M 177.29%	74.22M 45.48%	87.53M 17.94%
other expenses	-133K -	-205.17K 54.26%	-662K 222.67%	-18K 97.28%	356K 2,077.78%	2.86M 703.65%
cost and expenses	15.97M -	50.33M 215.16%	121.25M 140.92%	266.14M 119.50%	411.57M 54.64%	497.26M 20.82%
operating expenses	14.69M -	44.42M 202.40%	108.14M 143.48%	241.38M 123.20%	367.06M 52.07%	432.40M 17.80%
interest expense	887K -	920.46K 3.77%	1.14M 23.31%	295K 74.01%	294K 0.34%	196K 33.33%
ebitda	-8.90M -	1.30M 114.60%	18.24M 1,304.28%	10.98M 39.81%	-18.77M 270.97%	7.11M 137.89%
operating income	-9.14M -	801.49K 108.77%	18.42M 2,198.08%	6.67M 63.78%	-28.10M 521.15%	-3.63M 87.07%
depreciation and amortization	283K -	497.47K 75.78%	-178K 135.78%	4.31M 2,520.22%	9.33M 116.50%	10.74M 15.20%
total other income expenses net	-218K -	-1.99M 814.37%	-4.63M 132.28%	4.01M 186.67%	1.91M 52.31%	7.88M 311.60%
income before tax	-10.15M -	-1.19M 88.26%	13.79M 1,256.97%	10.69M 22.51%	-26.18M 345.06%	4.25M 116.22%
income tax expense	-126K -	715.29K 667.69%	-912K 227.50%	845K 192.65%	3.08M 264.73%	5.88M 90.85%
net income	-10.15M -	-1.91M 81.22%	13.79M 823.03%	9.84M 28.64%	-29.27M 397.43%	-1.64M 94.41%
weighted average shs out	38.37M -	38.37M 0%	32.03M 16.51%	49.82M 55.51%	52.84M 6.07%	56.77M 7.44%
weighted average shs out dil	44.95M -	44.95M 0%	51.55M 14.69%	55.59M 7.83%	52.84M 4.96%	56.77M 7.44%
eps	-0.26 -	-0.05 80.88%	0.43 965.19%	0.20 53.49%	-0.55 375%	-0.03 94.76%
epsdiluted	-0.23 -	-0.04 81.57%	0.27 736.79%	0.18 33.33%	-0.55 405.56%	-0.03 94.76%

COM:INARIMEDICAL

Inari Medical

Last Close

49.75

22/11 21:00

Market Cap

3.00B

Beta: -

Volume Today

590.81K

Avg: -

Preview